<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Varghese RT</submitter><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>National Institutes of Health</funding><pagination>549-555</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5946313</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(3)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured.&lt;h4>Methods&lt;/h4>Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieve</pubmed_abstract><journal>Diabetes, obesity &amp; metabolism</journal><pubmed_title>Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance.</pubmed_title><pmcid>PMC5946313</pmcid><funding_grant_id>5T32 DK007352-37</funding_grant_id><funding_grant_id>T32 DK007352</funding_grant_id><funding_grant_id>UL1 TR000135</funding_grant_id><funding_grant_id>R01 DK078646</funding_grant_id><funding_grant_id>R01 DK78646</funding_grant_id><pubmed_authors>Shah M</pubmed_authors><pubmed_authors>Cobelli C</pubmed_authors><pubmed_authors>Dalla Man C</pubmed_authors><pubmed_authors>Sharma A</pubmed_authors><pubmed_authors>Laurenti MC</pubmed_authors><pubmed_authors>Rizza RA</pubmed_authors><pubmed_authors>Bailey KR</pubmed_authors><pubmed_authors>Vella A</pubmed_authors><pubmed_authors>Varghese RT</pubmed_authors><pubmed_authors>Piccinini F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Performance of individually measured vs population-based C-peptide kinetics to assess β-cell function in the presence and absence of acute insulin resistance.</name><description>&lt;h4>Aims&lt;/h4>To compare the performance of population-based kinetics with that of directly measured C-peptide kinetics when used to calculate β-cell responsivity indices, and to study people with and without acute insulin resistance to ensure that population-based kinetics apply to all conditions where β-cell function is measured.&lt;h4>Methods&lt;/h4>Somatostatin was used to inhibit endogenous insulin secretion in 56 people without diabetes. Subsequently, a C-peptide bolus was administered and the changing concentrations were used to calculate individual kinetic measures of C-peptide clearance. In addition, the participants were studied on 2 occasions in random order using an oral glucose tolerance test (OGTT). On one occasion, free fatty acid elevation, to cause insulin resistance, was achieve</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2025-04-05T15:06:59.757Z</modification><creation>2019-06-06T19:29:39Z</creation></dates><accession>S-EPMC5946313</accession><cross_references><pubmed>28862812</pubmed><doi>10.1111/dom.13106</doi></cross_references></HashMap>